A retrospective study of the chemomobilization effect of AAE regime plus rhG-CSF in acute leukemia patients

被引：0
|
作者：
Shi, J. [1 ]
Luo, Y. [2 ]
Tan, Y. [2 ]
Huang, H. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB028
引用
收藏
页码：5565 / 5565
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing granulocytopenia in sarcoma patients receiving doxorubicin combined with ifosfamide: A prospective, randomized, non-inferiority phase II study.
    Fan, Li
    Ye, Ting
    Wang, Zhongliang
    Cao, Rubo
    Wang, Bicheng
    Peng, Ling
    Chen, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] The effect of rituximab in combination with MEVP chemotherapy and rhG-CSF in old patients of refractory and terminal non-Hodgkin's lymphoma.
    Qian, Meihua
    Wang, Wensong
    Lan, Jianping
    Wang, Lianming
    Zhan, Shumei
    Zhao, Zhonsen
    Xu, Wenjian
    BLOOD, 2006, 108 (11) : 257B - 258B
  • [33] Clinical observation on prevention of chemotherapy infection in gastric cancer by moxa-stick moxibustion plus rhG-CSF and its effect on immune function艾条灸联合rhG-CSF 预防胃癌化疗感染的临床观察及对免疫功能的影响
    Huan-huan Zhang
    Lei Shen
    Journal of Acupuncture and Tuina Science, 2020, 18 : 116 - 121
  • [34] Effect of rhG-CSF Treatment on Neonatal Cytokines Levels and Hematologic Values in Septic Premature Newborn Infants : A Double Blind Randomized Study ♦ 1468
    Renato S Procianoy
    Ernani Miura
    Clarissa S Miura
    Mauricio S Miura
    Cintia Mello
    Cristina Bittar
    Pediatric Research, 1998, 43 (Suppl 4) : 251 - 251
  • [35] RECOMBINANT HUMAN GLYCOSYLATED GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF)-COMBINED REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN REFRACTORY ACUTE MYELOID-LEUKEMIA
    TAKAHASHI, S
    OKAMOTO, SI
    SHIRAFUJI, N
    IKEBUCHI, K
    TANI, K
    SHIMANE, M
    MATSUDAIRA, T
    IRIE, S
    TSURUTA, T
    MATSUISHI, E
    OGURA, H
    KOUZAI, Y
    KODO, H
    TOJO, A
    SATOH, N
    OZAWA, K
    ASANO, S
    BONE MARROW TRANSPLANTATION, 1994, 13 (03) : 239 - 245
  • [36] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATION FACTOR (RHG-CSF) ON IMMUNE-SYSTEM IN PEDIATRIC-PATIENTS WITH APLASTIC-ANEMIA
    HIBI, S
    YOSHIHARA, T
    NAKAJIMA, F
    MISU, H
    MABUCHI, O
    IMASHUKU, S
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (03) : 319 - 323
  • [37] Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer
    A Fujita
    T Ohkubo
    H Hoshino
    H Takabatake
    S Tagaki
    K Sekine
    S Abe
    British Journal of Cancer, 2003, 89 : 1008 - 1012
  • [38] Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer
    Fujita, A
    Ohkubo, T
    Hoshino, H
    Takabatake, H
    Tagaki, S
    Sekine, K
    Abe, S
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 1008 - 1012
  • [39] Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
    Kakolyris, S
    Papadakis, E
    Tsiafaki, X
    Kalofonos, C
    Rapti, A
    Toubis, M
    Bania, E
    Kouroussis, C
    Chainis, K
    Androulakis, N
    Agelaki, S
    Sarra, E
    Vardakis, N
    Georgoulias, V
    LUNG CANCER, 2001, 32 (02) : 179 - 187
  • [40] Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer
    Fujita, A
    Takabatake, H
    Tagaki, S
    Sekine, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (04) : 279 - 283
12345